Variant report
Variant | esv2760266 |
---|---|
Chromosome Location | chr11:71282968-71288551 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:6)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:6 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71284028..71285602-chr11:71289697..71292475,2 | MCF-7 | breast: | |
2 | chr11:71282448..71285837-chr11:71286010..71289392,3 | MCF-7 | breast: | |
3 | chr11:71282448..71285837-chr11:71286010..71289392,3 | MCF-7 | breast: | |
4 | chr11:71158604..71160379-chr11:71280505..71283180,2 | MCF-7 | breast: | |
5 | chr11:71198072..71200599-chr11:71283906..71285709,2 | MCF-7 | breast: | |
6 | chr11:71162651..71164294-chr11:71282060..71284159,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000172890 | chromatin interactions |
ENSG00000254682 | chromatin interactions |
ENSG00000249387 | chromatin interactions |
ENSG00000172893 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140381273 | chr11:71282970-71282971 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs190683990 | chr11:71282972-71282973 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
3 | rs12286373 | chr11:71283013-71283014 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs372783778 | chr11:71283020-71283021 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs554765062 | chr11:71283023-71283024 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs561132110 | chr11:71283028-71283029 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs139885266 | chr11:71283057-71283058 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs574618806 | chr11:71283097-71283098 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs147355179 | chr11:71283113-71283114 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs112769627 | chr11:71283117-71283118 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs149284363 | chr11:71283163-71283164 | Weak transcription Enhancers | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs185426768 | chr11:71283188-71283189 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs538290622 | chr11:71283204-71283205 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs376009390 | chr11:71283289-71283290 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs550629581 | chr11:71283327-71283328 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs190285798 | chr11:71283345-71283346 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs111282476 | chr11:71283373-71283374 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs555553423 | chr11:71283378-71283379 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs144438777 | chr11:71283379-71283380 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs34620099 | chr11:71283411-71283412 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs534984373 | chr11:71283429-71283430 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs549040182 | chr11:71283456-71283457 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs373730433 | chr11:71283500-71283501 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs376425498 | chr11:71283509-71283510 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs58658505 | chr11:71283510-71283511 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs545098339 | chr11:71283515-71283516 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs111711183 | chr11:71283592-71283593 | Weak transcription Enhancers | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs563771597 | chr11:71283629-71283630 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs575823726 | chr11:71283712-71283713 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs542802484 | chr11:71283724-71283725 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs541823544 | chr11:71283728-71283729 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs561065124 | chr11:71283813-71283814 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs182519067 | chr11:71283831-71283832 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
34 | rs546858759 | chr11:71283836-71283837 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs567768200 | chr11:71283865-71283866 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
36 | rs532104796 | chr11:71283927-71283928 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs79741687 | chr11:71283943-71283944 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs568573955 | chr11:71283990-71283991 | Weak transcription Bivalent Enhancer | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs529745848 | chr11:71284017-71284018 | Weak transcription | Chromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs147190690 | chr11:71284043-71284044 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
41 | rs371132108 | chr11:71284057-71284058 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
42 | rs547930439 | chr11:71284058-71284059 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
43 | rs567509142 | chr11:71284065-71284066 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
44 | rs534920261 | chr11:71284092-71284093 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
45 | rs142513474 | chr11:71284102-71284103 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
46 | rs146628039 | chr11:71284104-71284105 | Weak transcription | Chromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
47 | rs4457774 | chr11:71284136-71284137 | Weak transcription | Chromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs113521093 | chr11:71284160-71284161 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs557086201 | chr11:71284187-71284188 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs369984142 | chr11:71284197-71284198 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71277600-71290400 | Weak transcription | Right Atrium | heart |
2 | chr11:71282000-71285000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr11:71282000-71290400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
4 | chr11:71282000-71290600 | Weak transcription | H9 Cell Line | embryonic stem cell |
5 | chr11:71282600-71290400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
6 | chr11:71282800-71283200 | Enhancers | Fetal Intestine Large | intestine |
7 | chr11:71282800-71283200 | Enhancers | Fetal Intestine Small | intestine |
8 | chr11:71282800-71283600 | Enhancers | H1 Cell Line | embryonic stem cell |
9 | chr11:71283000-71283200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr11:71283400-71285200 | Weak transcription | Fetal Kidney | kidney |
11 | chr11:71283800-71284000 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr11:71283800-71284000 | Bivalent Enhancer | HepG2 | liver |
13 | chr11:71285000-71285600 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr11:71285600-71291400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
15 | chr11:71286000-71288600 | Weak transcription | Fetal Kidney | kidney |
16 | chr11:71287000-71287600 | Enhancers | Brain Germinal Matrix | brain |